Some features of this website DO NOT support IE. Please use Chrome or Edge, or other browsers.

QT Medical is pleased to invite you to visit our booth at Healthcare+ Expo Taiwan !

We are honored to cordially invite you to visit our booth at Healthcare+ Expo Taiwan 2021

Improving Heart Health Right at Home

The facts are grim: One person dies from cardiovascular disease every 37 seconds in the United States. One of the most effective tests for the heart is the twelve-lead electrocardiogram (ECG).

At-Home Clinical ECG: Now and After The Pandemic – Interview with Dr. Ruey-Kang Chang, CEO, QT Medical

Many fields of medicine are undergoing a transformation due to the COVID-19 pandemic, as patients are kept away from clinics as much as possible.

QT Medical Selected as a Finalist for CONNECT’s 2018 Most Innovative New Product Awards

QT ECG is selected to be among 4 Finalists in the Life Science Research Tools and Medical Device Category

QT Medical receives the “Best Presenter Award” at the 2018 New York Venture Capital Summit

Dr Ruey-Kang Chang, CEO of QT Medical, garners praise at the Venture Capital Summit held in New York

QT Medical Receives U.S. FDA 510(k) Clearance for Home-use 12-lead ECG

QT Medical aims to bridge the gap between patients and healthcare providers using their cloud-based 12-lead ECG system to bring high quality cardiac care to homes.

QT Medical wins the People’s Choice Award in the American Telemedicine Association’s 2018 Pitch Jam

QT Medical, Inc., one of the six finalists, has won the People’s Choice Award in the American Telemedicine Association’s 2018 Pitch Jam competition taking place at the end of April 2018 in Chicago, IL, USA.

QT Medical CEO Dr. Ruey-Kang Chang Wins Digital Health Challenge Award at the Annual MedImmune California Translational Science Forum

Mountain View, California, September 26, 2017 – QT Medical, the leader in ECG technology, has announced that its CEO, Dr. Ruey-Kang Chang, has been awarded the grand prize of Digital Health Challenge - a competition held by MedImmune. The competition was part of the Digital Health Transforming Drug Development Translational Science Forum, hosted annually by MedImmune, the global biologics research and development arm of AstraZeneca.

Contact

This website uses cookies to collect information about your browsing session so we can provide the best experience possible.